30 USD
+0.25 (+0.84%)
30 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 88% to SYRE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.69. This target is 78.96% above the current price.
SYRE was analyzed by 19 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about SYRE.
In the previous month the buy percentage consensus was at a similar level.
SYRE was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | Deutsche Bank | Initiate | Buy |
| 2025-09-16 | BTIG | Reiterate | Buy -> Buy |
| 2025-04-08 | Leerink Partners | Initiate | Outperform |
| 2024-12-11 | Jones Trading | Initiate | Hold |
| 2024-11-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-25 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-04 | Wedbush | Initiate | Outperform |
| 2024-07-16 | Evercore ISI Group | Initiate | Outperform |
| 2024-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-10 | BTIG | Maintains | Buy -> Buy |
| 2024-05-02 | Baird | Initiate | Outperform |
| 2024-03-26 | Stifel | Reiterate | Buy -> Buy |
| 2024-03-01 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023-12-20 | BTIG | Initiate | Buy |
| 2023-12-18 | Stifel | Maintains | Buy -> Buy |
| 2023-12-11 | Guggenheim | Initiate | Buy |
| 2023-12-11 | Jefferies | Initiate | Buy |
| 2023-11-29 | TD Cowen | Initiate | Outperform |
SPYRE THERAPEUTICS INC / SYRE FAQ
What is the price target for SYRE stock?
19 analysts have analysed SYRE and the average price target is 53.69 USD. This implies a price increase of 78.96% is expected in the next year compared to the current price of 30.
Can you provide the consensus rating for SPYRE THERAPEUTICS INC stock?
The consensus rating for SPYRE THERAPEUTICS INC (SYRE) is 88.4211 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SPYRE THERAPEUTICS INC (SYRE)?
The number of analysts covering SPYRE THERAPEUTICS INC (SYRE) is 19.